Login / Signup

[Continuous glucose monitoring for better glucose control in type 2 diabetes?]

Philippe OriotLuc DerdelinckxJean-Christophe PhilipsRégis Pierre Radermecker
Published in: Revue medicale suisse (2024)
This article reviews the use of continuous glucose monitoring (CGM) devices in the management of type 2 diabetes (T2D). Study results show that continuous CGM use improves glycemic control, lowers glycated hemoglobin (HbA1c) levels, and reduces hypoglycemic episodes compared with traditional monitoring methods. -Observational studies also suggest a reduction in diabetes-related emergencies and hospitalizations. In addition, sporadic use of CGM appears to be beneficial for certain groups of people with T2D. However, more research is needed to fully understand the long-term effects and limitations of this technology. This article discusses -innovative perspectives on T2D management.
Keyphrases
  • glycemic control
  • type diabetes
  • blood glucose
  • weight loss
  • insulin resistance
  • cardiovascular disease
  • skeletal muscle
  • amyotrophic lateral sclerosis
  • drug induced
  • red blood cell